Quick Answer
Microbot Medical Inc. reported R&D Expense of $6.28 million for fiscal year 2025.
Microbot Medical Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $6.28M | -5.2% |
| 2024 | $6.63M | +15.8% |
| 2023 | $5.72M | -26.0% |
| 2022 | $7.74M | +25.7% |
| 2021 | $6.15M | +81.2% |
| 2020 | $3.40M | +11.4% |
| 2019 | $3.05M | +21.2% |
| 2018 | $2.52M | +128.6% |
| 2017 | $1.10M | +222.1% |
| 2016 | -$901.0K | -9.5% |
| 2015 | -$823.0K | -103.8% |
| 2014 | $21.50M | +0.0% |
| 2014 | $21.50M | +11.0% |
| 2013 | $19.37M | +31.9% |
| 2012 | $14.68M | -26.4% |
| 2011 | $19.94M | -5.1% |
| 2010 | $21.02M | +5.5% |
| 2009 | $19.93M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.17M | -43.2% | -44.5% |
| June 30, 2025 | $2.11M | +49.0% | +44.7% |
| March 31, 2025 | $1.46M | +24.8% | -29.2% |
| September 30, 2024 | $2.06M | +27.8% | +45.4% |
| June 30, 2024 | $1.42M | +3.8% | +21.2% |
| March 31, 2024 | $1.17M | -27.7% | -27.5% |
| September 30, 2023 | $1.61M | -17.5% | +18.1% |
| June 30, 2023 | $1.36M | -37.8% | -15.6% |
- Microbot Medical Inc. showed a decrease of -5.2% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, Microbot Medical Inc.’s r&d expense has declined by 68.5% (from $19.93 million to $6.28 million).
- The most recent figure is from Microbot Medical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: